Axsome Therapeutics, Inc.
corporate_fare Company Profile
Axsome Therapeutics, Inc. (NASDAQ:AXSM) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 21 items for AXSM at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Axsome Therapeutics Reports Strong Preliminary Q4 and Full Year 2025 Revenue Growth
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$638.5M
Net Income
-$183.17M
Diluted EPS
-$3.68
Op. Cash Flow
-$93.41M
Free Cash Flow
-$93.89M
Operating Income
-$166.76M
Cash & Equivalents
$322.93M
Total Debt
$187.75M
Debt / Equity
2.13×
Net Margin
-28.7%
Shares Outstanding
50.88M sh
Source: 10-K · filed 2026-02-23 · accession 0001193125-26-064267
show_chartPrice Chart
Loading chart...
feed AXSM - Filings & News (Page 2)
AXSM
Jan 12, 2026, 7:09 AM EST
Price at Filing:
$171.66
Real-time Price:
$129.36
Change:
-$42.30 (-25%)
Market Cap:
$6.804B